Ignoring warnings from the CDC and FDA, the U.S. Environmental Protection Agency (EPA) approved expanded use of streptomycin and oxytetracycline for the spraying of citrus crops. The approval will allow for up to 650,000 pounds of streptomycin to be used annually in agriculture, whereas humans in the US currently use 14,000 pounds of the antibiotic … Continue reading “EPA Allows Expanded Use of Antibiotics for Agriculture”
The FDA cleared the ERBEFLO 24-hour multipatient use port connector after a design modification added a backflow prevention feature to reduce the risk of cross-contamination of the irrigation system. The FDA clearance also required revised labeling to identify compatible endoscopes and accessories, as well as clear and specific warnings to assure proper use. Read more.
Heritage Pharmaceuticals has voluntarily recalled Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL), manufactured by Emcure Pharmaceuticals, due to detection of microbial growth in one lot which may indicate lack of sterility. Amikacin Sulfate Injection is indicated in the short-term treatment of serious infections due to susceptible strains of … Continue reading “Heritage Recalls Injections Due to Lack of Sterility”
APIC is taking strong steps to advocate for CMS to finalize proposed revisions to the Hospital/CAH Conditions of Participation (CoPs), which include the first update to infection prevention and control requirements since 1986 and includes a requirement for hospitals to establish antibiotic stewardship programs. Without further action, the proposed improvements will expire on June 16, … Continue reading “APIC increases advocacy for CMS CoPs and antibiotic stewardship programs”
The NHSN Biovigilance Team recently identified a defect in the Hemovigilance module that prevents users from submitting the Annual Facility Survey. On February 19, 2019 from 10am-1pm ET the module will be repaired to resolve the defect. The module will be unavailable for data entry during this time. While NHSN continues to fix this defect, … Continue reading “NHSN Hemovigilance Module defect identified”
FDA is warning compounders not to use glutathione-L-reduced powder distributed by Letco Medical, to compound sterile injectable drugs for patients. Based on reported adverse events, the agency has concerns about potential endotoxins in the product.
FDA announced that Smiths Medical is recalling the sterile saline and sterile water products for inhalation due to the potential exposure to infectious agents bacillus infantis and staphylococcus epidermidis because of damage to the containers used to package the finished products.
Registration is now open for the annual live training for users of the National Healthcare Safety Network (NHSN) Patient Safety Component and Outpatient Procedure Component. The training will be held March 25-29, 2019 at CDC in Atlanta. Registration for this event usual exceeds seating capacity, so registrants are chosen by lottery to attend in-person. Please … Continue reading “Register now for NHSN annual training”
APIC submitted comments to the HHS Office of the National Coordinator (ONC) for Health Information Technology on its draft Strategy on Reducing Burden Relating to the Use of Health IT and EHRs. The strategy, mandated by the 21st Century Cures Act, outlines three overarching goals designed to reduce clinician burden: 1.Reduce the effort and time … Continue reading “APIC submits comments on Health IT burden”
Read about the release of updates to NHSN, including the releases of Version 9.2, 2019 Patient Safety Component protocols, and the new Outpatient Procedure Component. •NHSN Version 9.2, released on December 8, includes many additions and changes, including analysis updates within the Patient Safety, Healthcare Personnel Safety, Dialysis, Long Term Care, Biovigilance and Outpatient Procedure … Continue reading “Important NHSN updates”